Early Outcomes of Triple Valve Replacement: A Single-center Experience

Introduction: The surgical treatment of aortic, mitral, and tricuspid valve diseases together remains a challenge as it is associated with a significantly high morbidity and mortality. The well-known risk factors, such as increased age, need for reoperation, and concomitant procedures, influence the outcomes of this complex and time-consuming surgery. Methods: To evaluate the early outcomes of patients who had undergone triple valve replacement (TVR) at our institute from January 2015 to June 2023. Results: A total of twenty patients were included in this study. In 18/20 (90%) patient’s bioprosthetic valve was used in the tricuspid position, whereas in all patients, mechanical prosthesis was used for the aortic and mitral positions. In-hospital mortality was 15% while the 1-year survival rate was 80%. A total of 5/20 (25%) patients required rehospitalization due to cardiac causes during the 1 st year after surgery, and prosthetic valve thrombosis was seen in 3/20 (15%) patients, all of which were treated medically. Conclusion: TVR is a challenging procedure, but advances in myocardial protection techniques, surgical techniques, and perioperative management have led to decrease in morbidity and mortality.